CFD
HRMY icon

Creative Financial Designs’s Harmony Biosciences HRMY Stock Holding History

Creative Financial Designs’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112 Buy
+4
New +$131 ﹤0.01% 2128

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Creative Financial Designs's HRMY Position: Q1 2026 in Review

Creative Financial Designs opened a new position in Harmony Biosciences (HRMY) in Q1 2026: 4 shares worth $112. The stake represents ﹤0.01% of the portfolio and ranks #2128 among its holdings.

309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Creative Financial Designs held 4 shares of Harmony Biosciences worth $112 as of Q1 2026.
  • Harmony Biosciences was a new Creative Financial Designs position in Q1 2026.
  • Harmony Biosciences made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #2128 holding.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.